Aldeyra Therapeutics Inc. buy BiotechBee
Start price
01.10.23
/
70%
€6.42
Target price
30.11.25
€10.00
Performance (%)
-73.55%
End price
16.10.23
€1.70
Summary
This prediction ended on 16.10.23 with a price of €1.70. The BUY prediction by BiotechBee for Aldeyra Therapeutics Inc. performed very badly with a performance of -73.55%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Aldeyra Therapeutics Inc. | 9.009% | 9.009% | -11.801% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to BiotechBee what are the pros and cons of Aldeyra Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aldeyra Therapeutics Inc. diskutieren
Buy mit Kursziel 10,0